Proteomika. Biomarcadores para el diagnóstico no invasivo de enfermedades complejas.

Clinical Research 

Proteomika collaborates with pharmaceutical and biotechnological companies in the field of biological drug and immunogenicity monitoring, molecular diagnosis and identification of biomarkers for complex diseases. Our Business Development Department is open to establishing new alliances and studying all new proposals.

Significant projects that are currently being developed in collaboration with businesses in the health sector are related to our programs aimed at the development and validation of immunoassays, identification of candidate biomarkers for gynecological conditions such as endometriosis and infertility. The novel biomarkers identified in these projects are then used for the development of non-invasive diagnostic tools.

Proteomika has extensive experience in the design, implementation and management of projects. We aim to provide an outstanding opportunity for companies interested in working with us in the creation, development and ongoing improvement of new products.